-

Pendulum Therapeutics Launches Metabolic Daily, a Unique Probiotic Blend that Optimizes Metabolism and Supports a Healthy Weight

Metabolic Daily naturally replenishes your gut microbiome, reduces sugar cravings and energy slumps, and boosts sugar and carb metabolism

SAN FRANCISCO--(BUSINESS WIRE)--Today, Pendulum Therapeutics, the biotech company pioneering the next frontier of metabolic health through its microbiome-targeted products, introduces its newest product: Metabolic Daily. Metabolic Daily is a proprietary probiotic blend that improves metabolism of sugar and carbohydrates. This live multi-strain probiotic naturally replenishes your gut microbiome to optimize metabolism, maintain healthy blood sugar levels and support a healthy weight.

“People talk about their metabolism all the time,” said Colleen Cutcliffe, Ph.D., Co-Founder and CEO at Pendulum. “People are always wondering how they can boost their metabolism and maintain healthy blood sugar levels. At Pendulum, we are always looking for safe, clinically-backed solutions that people can trust to help them reach their metabolic goals. We took these questions and requests and got to work developing a new probiotic blend that does just that.”

With its targeted formula, Metabolic Daily helps reduce sugar cravings and energy slumps to help provide balanced, sustained energy throughout the day. Metabolic Daily breaks down fiber and increases beneficial postbiotics and hormones, such as butyrate and GLP-1, which help maintain blood sugar levels. It is the first and only targeted probiotic to boost the metabolism that contains five powerful strains, including a keystone strain exclusive to Pendulum: Akkermansia muciniphila, whose effects are found in more than 1,000 science journals.

Metabolic Daily was formulated by a team of Ph.D. doctors and scientists from Johns Hopkins, Harvard, Berkeley and Stanford. The unique probiotic blend is encased in a plant-based, acid-resistant, delayed release capsule so that the strain gets through the stomach acid and to the gut microbiome where it can do its job.

Metabolic Daily retails at $49 for a 30-day supply for members, and $79 for a one-time purchase (30-day supply) on www.pendulumlife.com. Pendulum products are available online at Amazon, Pendulum Therapeutics website, Dr. Mark Hyman Store, Walmart Marketplace, Fullscript and The Cleveland Clinic online pharmacy.

About Metabolic Daily: Metabolic Daily is a live, multi-strain probiotic formulated by Ph.D. doctors and scientists from Johns Hopkins, Harvard, Berkeley, and Stanford who know that beneficial gut microbes directly influence energy metabolism. Basically, your gut microbiome regulates your metabolism by breaking down sugar, carbs, and fats. Metabolic Daily naturally replenishes your gut microbiome to optimize your metabolism and support a healthy weight. www.pendulumlife.com/products/pendulum-metabolic-daily

About Pendulum: Pendulum Therapeutics is disrupting the probiotics industry. Pioneering the next frontier to restore metabolic health, the biotech company develops microbiome-targeted products that have the power and efficacy of a pharmaceutical with the safety and accessibility of a probiotic. Led by Colleen Cutcliffe, Co-founder and CEO who received her Ph.D. in Biochemistry and Molecular Biology from Johns Hopkins University, Pendulum was founded in 2012 by a diverse team of scientists with deep microbiology, biochemistry, computational and clinical expertise. www.pendulumlife.com/

Contacts

Geena Dimaano
786.280.1277
View Hi-res Imagery HERE
pendulum@jacktaylorpr.com

Pendulum Therapeutics


Release Versions

Contacts

Geena Dimaano
786.280.1277
View Hi-res Imagery HERE
pendulum@jacktaylorpr.com

More News From Pendulum Therapeutics

Dr. Adam Perlman, Former Medical Director at Mayo Clinic, Joins Pendulum Therapeutics as Chief Medical Officer

SAN FRANCISCO--(BUSINESS WIRE)--Dr. Adam Perlman, Former Medical Director at Mayo Clinic, Joins Pendulum Therapeutics as Chief Medical Officer...

Pendulum Therapeutics Announces Strategic Partnership and $10M Investment From Global Nutrition Science Leader, Fonterra

SAN FRANCISCO--(BUSINESS WIRE)--Pendulum Therapeutics, the biotech company pioneering the next frontier of metabolic health through its microbiome-targeted products, announced today a strategic partnership with New Zealand dairy nutrition company Fonterra. Fonterra will invest $10 million into the growth-stage company to co-develop and commercialize next-generation microbiome products. The digestive health products market is exploding, sized at $51 billion globally (Source: Grandview). The stra...

Halle Berry, Long-Standing Pendulum Customer, Joins Company as Chief Communications Officer, and Becomes Equity Owner and Investor

SAN FRANCISCO--(BUSINESS WIRE)--Pendulum Therapeutics, the biotech company pioneering the next frontier of metabolic health through its microbiome-targeted products, today announced that Halle Berry, Academy Award® winning actress and director, has joined the company as equity owner, investor and Chief Communications Officer. As an avid Pendulum customer for over a year, Berry will now collaborate with Pendulum’s executive team on future product development and innovation. Acting as a brand eva...
Back to Newsroom